Clinical Study

NASHVILLE, Tennessee, August 20, 2026 Harrow, Inc. announced positive results from a prospective, randomized contralateral-eye study evaluating IHEEZO® (chloroprocaine...

Indianapolis, August 3, 2026 Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has granted...

Bad Homburg, Germany, August 3, 2026 Fresenius Kabi, an operating company of Fresenius, announced that the U.S. Food and...

San Jose, California, August 3, 2026 Invenio Imaging announced the completion of patient enrollment in the ON-SITE pivotal study,...

AUSTIN, Texas, July 22, 2026 Natera announced the publication of a prospective, multicenter study in JAMA Dermatology demonstrating that...

NASHVILLE, Tenn., July 20, 2026 Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America,...

GENEVA, Switzerland, July 9, 2026 MindMaze Therapeutics Holding SA has announced its support for a University of Pittsburgh clinical...

MAPLE GROVE, Minn., July 7, 2026 Francis Medical has announced that Orange County Urology Associates (OCUA) has become the...

BEVERLY, Mass., July 7, 2026 Akston Biosciences Corporation has announced encouraging preclinical data demonstrating that its investigational NGF-targeting Ambifect®...

ALAMEDA, Calif., July 7, 2026 Penumbra, Inc., a global leader in thrombectomy technologies, has announced the first patient enrollment...